Latest Period
Q2 2026
Security Snapshot
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) Institutional Ownership
CUSIP: 08205P209
13F Institutional Holders and Ownership History from Q3 2023 to Q2 2026
Institutions Reporting
86
Shares (Excl. Options)
33,138,760
Price
$13.38
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001
- Symbol
- BNTC on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 33,138,760
- Total 13F value
- $443,340,992
- Portfolio coverage rank
- 0%
- Share change
- +1,057,500
- Value change
- +$14,536,917
- Number of holders
- 86
- Shares outstanding
- 35,393,481
- SEC-reported price per share
- $11.89
- Insider filing price
- $11.89
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 is tracked under CUSIP 08205P209.
- 86 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 88 to 86 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $346,029,068 to $443,340,992.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 86 institutions filings for Q2 2026.
Security key
08205P209
Latest holder period
Q2 2026
13F holders
86
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
BNTC full holder history
Benitec Biopharma Inc. SEC filings
Benitec Biopharma Inc. company facts
Benitec Biopharma Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 08205P209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
BNTC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 44% | -12% | $249,200,088 | +$30,000,153 | 17,761,945 | +14% | SUVRETTA CAPITAL MANAGEMENT, LLC | 07 Nov 2025 |
| FRANKLIN RESOURCES INC | 11% | -29% | $50,561,782 | -$5,287,404 | 3,751,709 | -9.5% | Franklin Resources, Inc. | 31 Dec 2025 |
| JANUS HENDERSON GROUP PLC | 10% | -12% | $44,484,293 | -$292,158,468 | 3,382,836 | -87% | JANUS HENDERSON GROUP PLC | 28 Nov 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 5.5% | $24,327,500 | 1,850,000 | RA Capital Management, L.P. | 07 Nov 2025 | |||
| HBM Healthcare Investments (Cayman) Ltd. | 4.5% | $14,156,282 | 1,041,669 | HBM Healthcare Investments (Cayman) Ltd. | 31 Dec 2024 | |||
| Nantahala Capital Management, LLC | 4.4% | -53% | $14,111,462 | 1,038,371 | 0% | Nantahala Capital Management, LLC | 31 Mar 2025 |
As of 30 Jun 2026, 86 institutional investors reported holding 33,138,760 shares of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC). This represents 94% of the company’s total 35,393,481 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
91%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 33% | 11,548,351 | 0% | 3.2% | $154,516,936 |
| Jupiter Topco LLC | 7% | 2,478,547 | 0% | 0.01% | $33,113,388 |
| FRANKLIN RESOURCES INC | 6.8% | 2,412,888 | +1.5% | 0.01% | $32,284,447 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6% | 2,120,672 | 0% | 0.04% | $28,374,591 |
| RA CAPITAL MANAGEMENT, L.P. | 5.2% | 1,850,000 | 0% | 0.22% | $24,753,000 |
| Nantahala Capital Management, LLC | 4.2% | 1,488,371 | +3.5% | 1.2% | $19,914,404 |
| BlackRock, Inc. | 4% | 1,407,138 | +19% | 0% | $18,827,507 |
| Simplify Asset Management Inc. | 2.8% | 1,005,557 | +79% | 0.19% | $13,454,353 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.7% | 954,533 | +2.5% | 0% | $12,771,652 |
| INFINITUM ASSET MANAGEMENT, LLC | 2.6% | 923,006 | 0% | 1.3% | $12,349,820 |
| MILLENNIUM MANAGEMENT LLC | 2.6% | 921,299 | +41% | 0.01% | $12,326,981 |
| Alyeska Investment Group, L.P. | 2.1% | 750,000 | 0% | 0.03% | $10,035,000 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.9% | 679,826 | -5.3% | 1% | $9,096,072 |
| Balyasny Asset Management L.P. | 1.8% | 650,503 | -0.51% | 0.02% | $8,703,730 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 611,736 | +17% | 0% | $8,186,806 |
| AMERIPRISE FINANCIAL INC | 1.1% | 401,245 | -1.8% | 0% | $5,368,658 |
| STATE STREET CORP | 1.1% | 377,973 | +12% | 0% | $5,057,279 |
| MYDA Advisors LLC | 0.71% | 250,000 | +11% | 0.81% | $3,345,000 |
| Schonfeld Strategic Advisors LLC | 0.66% | 235,357 | +54% | 0.02% | $3,149,076 |
| AWM Investment Company, Inc. | 0.53% | 187,977 | 0% | 0.22% | $2,515,132 |
| NORTHERN TRUST CORP | 0.5% | 178,434 | +13% | 0% | $2,387,447 |
| GOLDMAN SACHS GROUP INC | 0.5% | 178,041 | -17% | 0% | $2,382,188 |
| VANGUARD FIDUCIARY TRUST CO | 0.45% | 160,995 | -6.3% | 0% | $2,154,113 |
| Burkehill Global Management, LP | 0.42% | 150,000 | 0% | 0.07% | $2,007,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.41% | 143,510 | +25% | 0% | $1,920,164 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
12
Latest
Q2 2026
Rows shown
1-12 of 12
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 33,138,760 | $443,340,992 | +$14,536,917 | $13.38 | 86 |
| 2026 Q1 | 32,483,197 | $346,029,068 | +$5,555,788 | $10.65 | 88 |
| 2025 Q4 | 31,662,101 | $426,562,132 | +$113,780,072 | $13.47 | 71 |
| 2025 Q3 | 23,155,291 | $324,725,438 | +$6,865,174 | $14.03 | 55 |
| 2025 Q2 | 22,685,530 | $265,306,276 | +$16,737,178 | $11.70 | 56 |
| 2025 Q1 | 21,243,183 | $277,395,506 | +$28,289,371 | $13.01 | 37 |
| 2024 Q4 | 18,997,897 | $240,166,135 | +$64,576,294 | $12.63 | 30 |
| 2024 Q3 | 13,715,023 | $126,792,177 | +$73,385,856 | $9.19 | 25 |
| 2024 Q2 | 5,729,459 | $39,940,820 | +$31,087,038 | $6.99 | 18 |
| 2024 Q1 | 1,270,837 | $6,576,960 | +$379,920 | $5.25 | 13 |
| 2023 Q4 | 1,197,615 | $3,880,452 | -$214,565 | $3.23 | 13 |
| 2023 Q3 | 1,267,947 | $3,838,114 | +$3,838,114 | $3.02 | 11 |